BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia
Clinical trial NCT01711632 · COMPLETED
Trial details
- NCT number
- NCT01711632
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2024-08-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.